IDEXX Laboratories Statistics
Share Statistics
IDEXX Laboratories has 80.42M
shares outstanding. The number of shares has increased by -1.87%
in one year.
Shares Outstanding | 80.42M |
Shares Change (YoY) | -1.87% |
Shares Change (QoQ) | -1.03% |
Owned by Institutions (%) | 87.28% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 58 |
FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 3M, so 3.7% of the outstanding
shares have been sold short.
Short Interest | 3M |
Short % of Shares Out | 3.7% |
Short % of Float | 4.83% |
Short Ratio (days to cover) | 2.44 |
Valuation Ratios
The PE ratio is 38.4 and the forward
PE ratio is 35.87.
IDEXX Laboratories's PEG ratio is
6.51.
PE Ratio | 38.4 |
Forward PE | 35.87 |
PS Ratio | 8.75 |
Forward PS | 7.5 |
PB Ratio | 21.37 |
P/FCF Ratio | 42.72 |
PEG Ratio | 6.51 |
Financial Ratio History Enterprise Valuation
IDEXX Laboratories has an Enterprise Value (EV) of 34.79B.
EV / Sales | 8.93 |
EV / EBITDA | 27.27 |
EV / EBIT | 37.45 |
EV / FCF | 43.6 |
Financial Position
The company has a current ratio of 1.31,
with a Debt / Equity ratio of 0.62.
Current Ratio | 1.31 |
Quick Ratio | 0.95 |
Debt / Equity | 0.62 |
Debt / EBITDA | 0.77 |
Debt / FCF | 1.24 |
Interest Coverage | 36.16 |
Financial Efficiency
Return on Equity is 55.65% and Return on Invested Capital is 33.87%.
Return on Equity | 55.65% |
Return on Assets | 26.96% |
Return on Invested Capital | 33.87% |
Revenue Per Employee | $354,318.55 |
Profits Per Employee | $80,715.18 |
Employee Count | 11,000 |
Asset Turnover | 1.18 |
Inventory Turnover | 3.98 |
Taxes
Income Tax | 221.96M |
Effective Tax Rate | 20% |
Stock Price Statistics
The stock price has increased by -2.2% in the
last 52 weeks. The beta is 1.52, so IDEXX Laboratories's
price volatility has been higher than the market average.
Beta | 1.52 |
52-Week Price Change | -2.2% |
50-Day Moving Average | 425.21 |
200-Day Moving Average | 447.34 |
Relative Strength Index (RSI) | 72.83 |
Average Volume (20 Days) | 876,945 |
Income Statement
In the last 12 months, IDEXX Laboratories had revenue of 3.9B
and earned 887.87M
in profits. Earnings per share was 10.77.
Revenue | 3.9B |
Gross Profit | 2.38B |
Operating Income | 1.13B |
Net Income | 887.87M |
EBITDA | 1.28B |
EBIT | 1.14B |
Earnings Per Share (EPS) | 10.77 |
Full Income Statement Balance Sheet
The company has 288.27M in cash and 986.95M in
debt, giving a net cash position of -698.68M.
Cash & Cash Equivalents | 288.27M |
Total Debt | 986.95M |
Net Cash | -698.68M |
Retained Earnings | 5.33B |
Total Assets | 3.21B |
Working Capital | 181.4M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 929M
and capital expenditures -130.92M, giving a free cash flow of 798.08M.
Operating Cash Flow | 929M |
Capital Expenditures | -130.92M |
Free Cash Flow | 798.08M |
FCF Per Share | 9.68 |
Full Cash Flow Statement Margins
Gross margin is 61.04%, with operating and profit margins of 28.95% and 22.78%.
Gross Margin | 61.04% |
Operating Margin | 28.95% |
Pretax Margin | 28.48% |
Profit Margin | 22.78% |
EBITDA Margin | 32.73% |
EBIT Margin | 28.95% |
FCF Margin | 20.48% |